Cheng-fan W. Lee
Taipei, TNQ 11031, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Metabolomics-Based Liquid Biopsy for Predicting Clinically Significant Prostate Cancer.
Journal: Cancers
Published: October 30, 2025
Decoding the S1P-S1PR axis in cancer: Mechanisms, pathways and therapeutic horizons (Review).
Journal: Biomedical reports
Published: August 29, 2025
Predicting Clinically Significant Prostate Cancer Using Urine Metabolomics via Liquid Chromatography Mass Spectrometry.
Journal: The world journal of men's health
Published: November 30, 2023
Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.
Journal: Journal of translational medicine
Published: April 27, 2023
Low Intake of Choline Is Associated with Diminished Strength and Lean Mass Gains in Older Adults.
Journal: The Journal of frailty & aging
Published: January 11, 2023
Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Journal: Oncogene
Published: November 10, 2021
The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC.
Journal: Clinical and translational medicine
Published: September 16, 2021
Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD.
Journal: Cancer research
Published: October 13, 2020
Gain-of-"endocytic' function in mutant p53 cancer cells.
Journal: The international journal of biochemistry & cell biology
Published: October 12, 2020
Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis.
Journal: Oncogene
Published: May 10, 2020
SPARC is a key mediator of TGF-β-induced renal cancer metastasis.
Journal: Journal of cellular physiology
Published: February 18, 2020
Last Updated: 09/26/2026